Search

Your search keyword '"Kordonouri, Olga"' showing total 746 results
Start Over "Kordonouri, Olga"

Refine your results

more »

more »

more »

more »

more »
746 results on '"Kordonouri, Olga"'

1. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

Author

Phillip, Moshe, Achenbach, Peter, Addala, Ananta, Albanese-O’Neill, Anastasia, Battelino, Tadej, Bell, Kirstine J., Besser, Rachel E. J., Bonifacio, Ezio, Colhoun, Helen M., Couper, Jennifer J., Craig, Maria E., Danne, Thomas, de Beaufort, Carine, Dovc, Klemen, Driscoll, Kimberly A., Dutta, Sanjoy, Ebekozien, Osagie, Larsson, Helena Elding, Feiten, Daniel J., Frohnert, Brigitte I., Gabbay, Robert A., Gallagher, Mary P., Greenbaum, Carla J., Griffin, Kurt J., Hagopian, William, Haller, Michael J., Hendrieckx, Christel, Hendriks, Emile, Holt, Richard I. G., Hughes, Lucille, Ismail, Heba M., Jacobsen, Laura M., Johnson, Suzanne B., Kolb, Leslie E., Kordonouri, Olga, Lange, Karin, Lash, Robert W., Lernmark, Åke, Libman, Ingrid, Lundgren, Markus, Maahs, David M., Marcovecchio, M. Loredana, Mathieu, Chantal, Miller, Kellee M., O’Donnell, Holly K., Oron, Tal, Patil, Shivajirao P., Pop-Busui, Rodica, Rewers, Marian J., Rich, Stephen S., Schatz, Desmond A., Schulman-Rosenbaum, Rifka, Simmons, Kimber M., Sims, Emily K., Skyler, Jay S., Smith, Laura B., Speake, Cate, Steck, Andrea K., Thomas, Nicholas P. B., Tonyushkina, Ksenia N., Veijola, Riitta, Wentworth, John M., Wherrett, Diane K., Wood, Jamie R., Ziegler, Anette-Gabriele, and DiMeglio, Linda A.

Published
2024
Full Text
View/download PDF

2. Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes

Author

Phillip, Moshe, Achenbach, Peter, Addala, Ananta, Albanese‑O’Neill, Anastasia, Battelino, Tadej, Bell, Kirstine J., Besser, Rachel E. J., Bonifacio, Ezio, Colhoun, Helen M., Couper, Jennifer J., Craig, Maria E., Danne, Thomas, de Beaufort, Carine, Dovc, Klemen, Driscoll, Kimberly A., Dutta, Sanjoy, Ebekozien, Osagie, Larsson, Helena Elding, Feiten, Daniel J., Frohnert, Brigitte I., Gabbay, Robert A., Gallagher, Mary P., Greenbaum, Carla J., Griffin, Kurt J., Hagopian, William, Haller, Michael J., Hendrieckx, Christel, Hendriks, Emile, Holt, Richard I. G., Hughes, Lucille, Ismail, Heba M., Jacobsen, Laura M., Johnson, Suzanne B., Kolb, Leslie E., Kordonouri, Olga, Lange, Karin, Lash, Robert W., Lernmark, Åke, Libman, Ingrid, Lundgren, Markus, Maahs, David M., Marcovecchio, M. Loredana, Mathieu, Chantal, Miller, Kellee M., O’Donnell, Holly K., Oron, Tal, Patil, Shivajirao P., Pop‑Busui, Rodica, Rewers, Marian J., Rich, Stephen S., Schatz, Desmond A., Schulman‑Rosenbaum, Rifka, Simmons, Kimber M., Sims, Emily K., Skyler, Jay S., Smith, Laura B., Speake, Cate, Steck, Andrea K., Thomas, Nicholas P. B., Tonyushkina, Ksenia N., Veijola, Riitta, Wentworth, John M., Wherrett, Diane K., Wood, Jamie R., Ziegler, Anette‑Gabriele, and DiMeglio, Linda A.

Published
2024
Full Text
View/download PDF

3. Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic

Author

Zeller, Ivo, Weiss, Andreas, Arnolds, Stefanie, Schütte-Borkovec, Katharina, Arabi, Sari, von dem Berge, Thekla, Casteels, Kristina, Hommel, Angela, Kordonouri, Olga, Larsson, Helena Elding, Lundgren, Markus, Rochtus, Anne, Snape, Matthew D., Szypowka, Agnieszka, Vatish, Manu, Winkler, Christiane, Bonifacio, Ezio, and Ziegler, Anette-Gabriele

Published
2024
Full Text
View/download PDF

4. Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes

Author

Hummel, Sandra, Rosenberger, Sarah, von dem Berge, Thekla, Besser, Rachel E. J., Casteels, Kristina, Hommel, Angela, Kordonouri, Olga, Elding Larsson, Helena, Lundgren, Markus, Marcus, Benjamin A., Oltarzewski, Mariusz, Rochtus, Anne, Szypowska, Agnieszka, Todd, John A., Weiss, Andreas, Winkler, Christiane, Bonifacio, Ezio, and Ziegler, Anette-G.

Published
2024
Full Text
View/download PDF

23. Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents.

Author

Holder, Martin, Kapellen, Thomas, Ziegler, Ralph, Bürger-Büsing, Jutta, Danne, Thomas, Dost, Axel, Holl, Reinhard W., Holterhus, Paul-Martin, Karges, Beate, Kordonouri, Olga, Lange, Karin, Müller, Susanne, Raile, Klemens, Schweizer, Roland, von Sengbusch, Simone, Stachow, Rainer, Wagner, Verena, Wiegand, Susanna, and Neu, Andreas

Subjects
DIABETES in children, AUTOIMMUNE diseases, HEART failure, MATURITY onset diabetes of the young, DIABETES, DIAGNOSIS, TYPE 2 diabetes
Abstract

This document is a summary of an article from the journal Experimental & Clinical Endocrinology & Diabetes titled "Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents." The article provides comprehensive information on the diagnosis, therapy, and follow-up of diabetes in this age group. It covers topics such as epidemiology, types of diabetes, risk factors, prevention, and early detection. The article emphasizes the importance of immediate insulin therapy after diagnosis and recommends specialized care for children with diabetes. It also discusses the psychosocial aspects of long-term care, the importance of a multi-professional team, and the treatment of acute and long-term complications. The document provides guidelines for the diagnosis and treatment of various types of diabetes in children and adolescents, including associated autoimmune diseases. It was prepared by the German Diabetes Society with input from experts in the field. [Extracted from the article]

Published
2024
Full Text
View/download PDF

26. Elevations in blood glucose before and after the appearance of islet autoantibodies in children

Author

Warncke, Katharina, Weiss, Andreas, Achenbach, Peter, von dem Berge, Thekla, Berner, Reinhard, Casteels, Kristina, Groele, Lidia, Hatzikotoulas, Konstantinos, Hommel, Angela, Kordonouri, Olga, Larsson, Helena Elding, Lundgren, Markus, Marcus, Benjamin A., Snape, Matthew D., Szypowska, Agnieszka, Todd, John A., Bonifacio, Ezio, and Ziegler, Anette-G.

Subjects
Islands of Langerhans -- Physiological aspects -- Health aspects, Autoimmunity -- Health aspects, Type 1 diabetes -- Risk factors -- Development and progression, Blood sugar -- Measurement -- Health aspects, Pediatric research, Health care industry
Abstract

The etiology of type 1 diabetes has polygenic and environmental determinants that lead to autoimmune responses against pancreatic [beta] cells and promote [beta] cell death. The autoimmunity is considered silent without metabolic consequences until late preclinical stages,and it remains unknown how early in the disease process the pancreatic [beta] cell is compromised. To address this, we investigated preprandial nonfasting and postprandial blood glucose concentrations and islet autoantibody development in 1,050 children with high genetic risk of type 1 diabetes. Pre- and postprandial blood glucose decreased between 4 and 18 months of age and gradually increased until the final measurements at 3.6 years of age. Determinants of blood glucose trajectories in the first year of life included sex, body mass index, glucose-related genetic risk scores, and the type 1 diabetes-susceptible INS gene. Children who developed islet autoantibodies had early elevations in blood glucose concentrations. A sharp and sustained rise in postprandial blood glucose was observed at around 2 months prior to autoantibody seroconversion, with further increases in postprandial and, subsequently, preprandial values after seroconversion. These findings show heterogeneity in blood glucose control in infancy and early childhood and suggest that islet autoimmunity is concurrent or subsequent to insults on the pancreatic islets., Introduction The supply, uptake, and metabolism of glucose are cornerstones of energy production for cell and organ function and survival. Blood glucose levels are regulated by a multitude of hormones [...]

Published
2022
Full Text
View/download PDF

32. Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes.

Author

Hendriks, A. Emile J., Marcovecchio, M. Loredana, Besser, Rachel E. J., Bonifacio, Ezio, Casteels, Kristina, Elding Larsson, Helena, Gemulla, Gita, Lundgren, Markus, Kordonouri, Olga, Mallone, Roberto, Pociot, Flemming, Szypowska, Agnieszka, Toppari, Jorma, Berge, Thekla von dem, Ziegler, Anette G., Mathieu, Chantal, Achenbach, Peter, Mathieu, C., Gillard, P., and Casteels, K.

Subjects
TYPE 1 diabetes, AUTOIMMUNE diseases, CLINICAL medicine, CONTINUOUS glucose monitoring, AUTOANTIBODIES, DIABETIC acidosis, MEDICAL screening
Abstract

Background/Aim: Type 1 diabetes is an autoimmune disease that involves the development of autoantibodies against pancreatic islet beta‐cell antigens, preceding clinical diagnosis by a period of preclinical disease activity. As screening activity to identify autoantibody‐positive individuals increases, a rise in presymptomatic type 1 diabetes individuals seeking medical attention is expected. Current guidance on how to monitor these individuals in a safe but minimally invasive way is limited. This article aims to provide clinical guidance for monitoring individuals with presymptomatic type 1 diabetes to reduce the risk of diabetic ketoacidosis (DKA) at diagnosis. Methods: Expert consensus was obtained from members of the Fr1da, GPPAD, and INNODIA consortia, three European diabetes research groups. The guidance covers both specialist and primary care follow‐up strategies. Results: The guidance outlines recommended monitoring approaches based on age, disease stage and clinical setting. Individuals with presymptomatic type 1 diabetes are best followed up in specialist care. For stage 1, biannual assessments of random plasma glucose and HbA1c are suggested for children, while annual assessments are recommended for adolescents and adults. For stage 2, 3‐monthly clinic visits with additional home monitoring are advised. The value of repeat OGTT in stage 1 and the use of continuous glucose monitoring in stage 2 are discussed. Primary care is encouraged to monitor individuals who decline specialist care, following the guidance presented. Conclusions: As type 1 diabetes screening programs become more prevalent, effective monitoring strategies are essential to mitigate the risk of complications such as DKA. This guidance serves as a valuable resource for clinicians, providing practical recommendations tailored to an individual's age and disease stage, both within specialist and primary care settings. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

Author

Phillip, Moshe, Nimri, Revital, Bergenstal, Richard M, Barnard-Kelly, Katharine, Danne, Thomas, Hovorka, Roman, Kovatchev, Boris P, Messer, Laurel H, Parkin, Christopher G, Ambler-Osborn, Louise, Amiel, Stephanie A, Bally, Lia, Beck, Roy W, Biester, Sarah, Biester, Torben, Blanchette, Julia E, Bosi, Emanuele, Boughton, Charlotte K, Breton, Marc D, Brown, Sue A, Buckingham, Bruce A, Cai, Albert, Carlson, Anders L, Castle, Jessica R, Choudhary, Pratik, Close, Kelly L, Cobelli, Claudio, Criego, Amy B, Davis, Elizabeth, de Beaufort, Carine, de Bock, Martin I, DeSalvo, Daniel J, DeVries, J Hans, Dovc, Klemen, Doyle, Francis J, Ekhlaspour, Laya, Shvalb, Naama Fisch, Forlenza, Gregory P, Gallen, Geraldine, Garg, Satish K, Gershenoff, Dana C, Gonder-Frederick, Linda A, Haidar, Ahmad, Hartnell, Sara, Heinemann, Lutz, Heller, Simon, Hirsch, Irl B, Hood, Korey K, Isaacs, Diana, Klonoff, David C, Kordonouri, Olga, Kowalski, Aaron, Laffel, Lori, Lawton, Julia, Lal, Rayhan A, Leelarathna, Lalantha, Maahs, David M, Murphy, Helen R, Nørgaard, Kirsten, O'Neal, David, Oser, Sean, Oser, Tamara, Renard, Eric, Riddell, Michael C, Rodbard, David, Russell, Steven J, Schatz, Desmond A, Shah, Viral N, Sherr, Jennifer L, Simonson, Gregg D, Wadwa, R Paul, Ward, Candice, Weinzimer, Stuart A, Wilmot, Emma G, Battelino, Tadej, General Internal Medicine, APH - Health Behaviors & Chronic Diseases, and AGEM - Amsterdam Gastroenterology Endocrinology Metabolism

Subjects
closed-loop, Endocrinology, consensus recommendations, automated insulin delivery, type 1 diabetes, Endocrinology, Diabetes and Metabolism, 610 Medicine & health, 610 Medizin und Gesundheit
Abstract

The significant and growing global prevalence of diabetes continues to challenge people with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal glucose levels has been shown to prevent or delay the progression of the long-term complications of diabetes, a significant proportion of PwD are not attaining their glycemic goals. During the past 6 years, we have seen tremendous advances in automated insulin delivery (AID) technologies. Numerous randomized controlled trials and real-world studies have shown that the use of AID systems is safe and effective in helping PwD achieve their long-term glycemic goals while reducing hypoglycemia risk. Thus, AID systems have recently become an integral part of diabetes management. However, recommendations for using AID systems in clinical settings have been lacking. Such guided recommendations are critical for AID success and acceptance. All clinicians working with PwD need to become familiar with the available systems in order to eliminate disparities in diabetes quality of care. This report provides much-needed guidance for clinicians who are interested in utilizing AIDs and presents a comprehensive listing of the evidence payers should consider when determining eligibility criteria for AID insurance coverage.

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results